PharmaVOICE - 
June 2021
Purchase Issue
In Every Issue
Letter from the Editor
The clinical trial horizon The rise of decentralized clinical trials, [...]
By

Taren Grom, Editor

Upfront
Yankees Legend Bernie Williams Raises Awareness of IPF with Boehringer [...]
By

PharmaVOICE Staff

HealthTech
Walmart Acquires Telehealth Company MeMD Trend Watch: Major Retailers Walmart [...]
By

PharmaVOICE Staff

Artificial Intelligence
Microsoft Buys Conversational AI Nuance Trend Watch: Investments in AI [...]
By

PharmaVOICE Staff

On The Cover

Personalized Medicine: A Work in Progress
Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine. The advent of big data is transforming both life-sciences research and the practice of healthcare. In recent years, advances in the collection of molecular, [...]
By

Carolyn Gretton

Features

SHOWCASE: Clinical Trial Solutions: The Changing Face of Clinical Trial Solutions
Clinical trials have undergone significant change over the past year amid concerns over patient safety during the pandemic. According to a survey across biopharmaceutical companies, medical devices companies and clinical research organizations, 76% have sped up the move to virtual in the wake of COVID-19. The cost of delaying clinical trials is significant to companies, [...]
By

PharmaVOICE Staff

Meeting the Demands of Today to Create the Treatments of Tomorrow
In our rapidly evolving clinical research industry, there’s never been a more important time to ensure you’re getting the most out of your central laboratory services. This is especially true in the face of the challenges brought about by the COVID-19 pandemic. While the landscape of clinical research continues to evolve and shift, the criticality [...]
By

Tom Mueller, Chief Commercial Officer, ACM Global Laboratories

Lessons Learned from COVID-19
Why CROs Must Continue Modeling Support and Compassion to Clinical Sites When the COVID-19 pandemic hit in March 2020, a range of emotions followed, including shock and uncertainty. However, what we began to see was an increase in kindness and compassion both at home and at work. Faced with the challenges of adjusting to life [...]
By

Sheri Madrid, Executive Director, Clinical Operations and Doug Lested, Program Director, Advanced Clinical

The Benefits of Flexible, Decentralized Trial Designs — And How to Make Them Happen
Clinical trial managers have used digital technology for several years to some degree. Now, because of the pandemic, digital technology has become a proven and valuable necessity. However, for all the benefits of bring your own device (BYOD), electronic patient-reported outcomes (ePRO), and direct data capture (DDC), historically, design and implementation challenges have hindered widespread [...]
By

Jonathan Andrus, Chief Business Officer, Clinical Ink

Seven Secrets to Patient Experience Breakthroughs
The principles of behavioral science can be used to keep participants engaged, adherent to the protocol, and proud of the contributions to curing disease. Consumer industries have invested millions in improving “customer experience” — how consumers feel or perceive every interaction with a company. In clinical trials, the notion of “patient experience” has received comparatively [...]
By

Kyle Hogan, Executive VP, Datacubed Health

Decentralization of Clinical Trials: Taking Into Account All Stakeholder Perspectives
At first, the COVID-19 pandemic threatened clinical research, with patients struggling to get to sites, hospitals becoming overloaded, and screening criteria becoming increasingly muddled due to widely circulating symptoms. However, the industry rallied to rapidly adapt and enable decentralization of clinical trials with community-based solutions, telehealth, and the assistance of connected devices capable of expanding [...]
By

Matthew McCarty, Chief Strategy & Marketing Officer, Elisa Cascade,Executive VP and Product Line Executive, eCOA, and Matthew Johnson, VP, Wearables and Digital Biomarkers, ERT

Data-Driven Outreach Drives Rapid Recruiting
The pandemic has accomplished something that the pharma industry has been trying to achieve for years: it got consumers excited about clinical research. The rush to develop vaccines and 24/7 coverage of the virus’ spread captivated audiences and made all populations more aware of trial participation. By leveraging the momentum of this unexpected education in [...]
By

Mark Brown, VP, Global Patient and Site Solutions, IQVIA

Widening the Lens: From Patient Engagement to Community Engagement
To truly engage patients, we must incorporate their community support systems No patient travels through their health journey alone. To be patient-centric, and fully engage patients in clinical research, expanding our approach to be inclusive of the broader communities that support them is imperative. Community engagement is all encompassing — beyond the patient, the provider, [...]
By

Alycia James, Patient Experience Advisor and Amanda Wright, VP, Partnership Development, Javara, Inc.

AI in Clinical Trials: An Incredible Voyage
The 19th century English naturalist and seafarer Charles Darwin once said: “It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change.” He knew a thing or two about evolution. So does the life-sciences industry — especially after last year when our ability to evolve [...]
By

Jonathan Burr, Senior VP, Clinical Platform Strategy, Saama Technologies

Fulfilling the Promise of Wearables in Clinical Trials
Wearable sensors have the power to transform clinical trials and, indeed, medicine in general, by replacing sporadic, often subjective health measures with continuous, objective ones. Instead of doctors asking their patients during occasional visits whether they have been sleeping well or been active, wearables can answer precisely how much they have been sleeping, how active [...]
By

Geoffrey Gill, President, Shimmer Americas, Shimmer Research Inc.

Decentralized Trials: Moving Beyond One-Size-Fits-All
Suppose there’s a problem with your car’s suspension, you pull up to a service station, and the mechanic starts talking about replacing the engine and wheels. The scenario sounds comical, but it captures what could happen if a hasty, soup-to-nuts research approach is misapplied to decentralized clinical trials (DCTs). In this fast-growing area, where research [...]
By

Noolie Gregory, VP, Operations Management, Decentralized Solutions and Scott Scarola, VP, Operations Management, Syneos Health

The Financial Benefits of Incorporating Decentralized Clinical Trial (DCT) Approaches
Clinical research trials are expensive to conduct and continue to rise in cost. Studies by Tufts and JAMA in recent years calculate the average cost to bring a drug to market steadily increasing to more than a billion U.S. dollars1. These rising research costs restrict R&D budgets for drug and device manufacturers, limiting the investments [...]
By

John Reites , CEO, THREAD

Collaborations Across the Ecosystem
Over the past couple of years, there has been an increase in the number of collaborations designed to accelerate progress to solve R&D and patient challenges. Daiichi Sankyo and AstraZeneca Tackle Cancer Ken Takeshita, M.D., Global Head of Research and Development Daiichi Sankyo Cristian Massacesi, M.D. Senior VP, Head of Late Development Oncology R&D AstraZeneca [...]
By

Taren Grom, Editor

Marketing to Zoomers
Pharma needs to gear up for the 2 billion Gen Zers about to enter the marketplace. If you’re looking for a snapshot of what Gen Z, or zoomers, means as an audience for your product, consider this: 16-year-old Swedish climate activist Greta Thunberg is a zoomer. Mari Copeny, who wrote a letter to President Obama [...]
By

Robin Robinson

A Public Crisis — Health Inequity
Tackling the link between health inequities, social injustice, and social determinants of health. The World Health Organization describes health as a fundamental human right. Yet, in much of the world, including the United States, health and social inequity are pervasive problems that systematically push already marginalized communities further into poor health. The national health initiative [...]
By

Kim Ribbink

Commanders & Chiefs: Chief Medical Officers
It comes as no surprise that the pandemic forced companies to consider appointing medical officers to senior executive ranks. The majority of companies had to create a brand new role to lead the pandemic response and address the needs of organizations to manage global healthcare risks and exposures. According to the workforce analytics firm Burning [...]
By

PharmaVOICE Staff

FEEDBACK